超声内镜剪切波弹性成像与经皮肝硬度检测诊断准确性比较:一项先导研究
这是一项单中心、前瞻性、非随机串联研究,连续纳入因无创检测不可靠而接受肝活检的患者,比较超声内镜剪切波弹性成像(EUS-SWE)与振动控制瞬时弹性成像(VCTE)对肝纤维化的诊断准确性。42例患者(39男,年龄54.5±12.1岁)均接受EUS-SWE、VCTE和肝活检。EUS-SWE与肝组织学相关性好,诊断准确性与VCTE相当,两者AUROC无统计学显著差异。
要点
- 在VCTE不可靠的患者中,EUS-SWE仍可成功完成检查。
- EUS-SWE对进展期纤维化和肝硬化的诊断准确性与VCTE相当。
- EUS-SWE与VCTE的AUROC无统计学显著差异。
核心结论
- EUS-SWE与肝组织学相关性好,是评估肝纤维化的安全可靠诊断方法,准确性可与VCTE相当。
研究设计与样本
- 单中心、前瞻性、非随机串联研究,连续纳入因无创检测不可靠而接受肝活检的患者。
- 共42例患者(39男,年龄54.5±12.1岁)接受EUS-SWE、VCTE和肝活检。
- EUS-SWE分别对左叶和右叶进行,并与VCTE比较;肝弹性 cutoff 通过Youden指数优化敏感度和特异度,以及将敏感度和特异度分别固定为90%三种方式估算。
- 主要结局为EUS-SWE对进展期纤维化的诊断准确性;次要结局为VCTE及EUS-SWE左、右叶对显著/进展期纤维化和肝硬化的诊断准确性。
- 临床试验注册号:NCT04533932。
主要发现
- 进展期纤维化的交叉验证AUROC:VCTE为.87(95%CI .76-.97),EUS-SWE左叶为.8(95%CI .64-.96),EUS-SWE右叶为.78(95%CI .62-.95)。
- 肝硬化的AUROC:VCTE为.9(95%CI .83-.97),EUS-SWE左叶为.96(95%CI .9-1),EUS-SWE右叶为.9(95%CI .8-1)。
- VCTE在8例患者中不可靠,这些患者均成功完成EUS-SWE。
- EUS-SWE与VCTE的AUROC无统计学显著差异。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Vibration-controlled transient elastography (VCTE) is a validated test for assessing liver fibrosis but may be unreliable in select patients, including those with morbid obesity. The limitations of VCTE may be overcome by EUS-guided shear wave elastography (EUS-SWE). METHODS: This single-center, prospective, nonrandomized tandem study compared the diagnostic accuracy of EUS-SWE and VCTE in consecutive patients undergoing liver biopsy sampling because of unreliable noninvasive testing. EUS-SWE of the left and right lobes were separately performed and then compared with VCTE. Liver elasticity cutoffs for different stages of fibrosis were estimated in 3 ways: optimized sensitivity and specificity using the Youden index; and with sensitivity and specificity fixed at 90% each, Diagnostic accuracy for fibrosis was compared with liver histology using the area under the receiver-operating characteristic curve (AUROC). The primary outcome was the diagnostic accuracy of EUS-SWE for advanced fibrosis. Secondary outcomes were diagnostic accuracy of VCTE, EUS-SWE for left and right hepatic lobes for significant/advanced fibrosis, and cirrhosis. RESULTS: Forty-two patients (39 men, aged 54.5 ± 12.1 years) underwent EUS-SWE, VCTE, and liver biopsy sampling. The cross-validated AUROCs for advanced fibrosis were as follows: VCTE, .87 (95% confidence interval [CI], .76-.97); EUS-SWE left lobe, .8 (95% CI, .64-.96); and EUS-SWE right lobe, .78 (95% CI, .62-.95). The corresponding AUROCs for cirrhosis were as follows: VCTE, .9 (95% CI, .83-.97); EUS-SWE left lobe, .96 (95% CI, .9-1); and EUS-SWE right lobe, .9 (95% CI, .8-1). VCTE was unreliable in 8 patients who successfully underwent EUS-SWE. There was no statistically significant difference in the AUROCs for EUS-SWE and VCTE. CONCLUSIONS: EUS-SWE correlates well with liver histology and is a safe and reliable diagnostic test for assessing liver fibrosis with accuracy comparable with VCTE. (Clinical trial registration number: NCT04533932.).
引用
- Kohli DR, Mettman D, Andraws N, et al. Comparative accuracy of endosonographic shear wave elastography and transcutaneous liver stiffness measurement: a pilot study. Gastrointest Endosc. 2022. PMID: 36049537. doi:10.1016/j.gie.2022.08.035
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。